Search Results - "Muscular Dystrophy"

CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2 by Javier Poyatos-García, Águeda Blázquez-Bernal, Marta Selva-Giménez, Ariadna Bargiela, Jorge Espinosa-Espinosa, Rafael P. Vázquez-Manrique, Anne Bigot, Ruben Artero, Juan Jesús Vilchez

Connect to this object online.

Motor Control of Gait and the Underlying Neural Network in Pediatric Neurology

Subjects: “…Duchenne muscular dystrophy…”
DOAB: download the publication
DOAB: description of the publication

CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene by Tatiana V. Egorova, Evgenia D. Zotova, Denis A. Reshetov, Anna V. Polikarpova, Svetlana G. Vassilieva, Dmitry V. Vlodavets, Alexey A. Gavrilov, Sergey V. Ulianov, Vladimir L. Buchman, Alexei V. Deykin

Connect to this object online.

Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP^® Neonatal Creatine Kinase-MM Kit in a US and Danish Population by Anne Timonen, Michele Lloyd-Puryear, David M. Hougaard, Liisa Meriö, Pauliina Mäkinen, Ville Laitala, Tuukka Pölönen, Kristin Skogstrand, Annie Kennedy, Sari Airenne, Hanna Polari, Teemu Korpimäki

Connect to this object online.

Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology by Aqsa Iqbal, Ulrike May, Stuart N. Prince, Tero A.H. Järvinen, Ahlke Heydemann

Connect to this object online.

Sudden cardiac death of Duchenne muscular dystrophy with NT-proBNP in pericardial fluid as a useful biomarker for diagnosis of the cause of death: a case report by Mengzhou Zhang, Rui Zhao, Tianshui Yu, Jiaoyong Li, Miao Zhang, Shukun Jiang, Linlin Wang, Guohua Zhang, Rubo Li, Baoli Zhu, Dawei Guan

Connect to this object online.

Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study by Zhiqiang Wang, Liangliang Qiu, Minting Lin, Long Chen, Fuze Zheng, Lin Lin, Feng Lin, Zhixian Ye, Xiaodan Lin, Junjie He, Lili Wang, Xin Lin, Qifang He, Wanjin Chen, Yi Lin, Ying Fu, Ning Wang

Connect to this object online.

Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations by Mohd Saeed, Ashanul Haque, Ambreen Shoaib, Syed Mohd Danish Rizvi

Connect to this object online.

Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy by Brooke A. Migliore, Linran Zhou, Martin Duparc, Veronica R. Robles, Catherine W. Rehder, Holly L. Peay, Katerina S. Kucera

Connect to this object online.

Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores by Jonathan H. Soslow, Larry W. Markham, Larry W. Markham, W. Bryan Burnette, Cristi L. Galindo, Igor Feoktistov, Frank J. Raucci, Bruce M. Damon, Douglas B. Sawyer, Douglas B. Sawyer, Sergey Ryzhov

Connect to this object online.

Identification of a novel LAMA2 c.2217G > A, p.(Trp739*) mutation in a Moroccan patient with congenital muscular dystrophy: a case report by Youssef El Kadiri, Ilham Ratbi, Fatima Zahra Laarabi, Yamna Kriouile, Abdelaziz Sefiani, Jaber Lyahyai

Connect to this object online.

Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy by Alberto Malerba, Jagjeet K Kang, Graham McClorey, Amer F Saleh, Linda Popplewell, Michael J Gait, Matthew JA Wood, George Dickson

Connect to this object online.

Systemic administration of the antisense oligonucleotide NS‐089/NCNP‐02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial by Takami Ishizuka, Hirofumi Komaki, Yasuko Asahina, Harumasa Nakamura, Norio Motohashi, Eri Takeshita, Yuko Shimizu‐Motohashi, Akihiko Ishiyama, Chihiro Yonee, Shinsuke Maruyama, Eisuke Hida, Yoshitsugu Aoki

Connect to this object online.

Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function

Subjects: “…Emery-Dreifuss muscular dystrophy…”
DOAB: download the publication
DOAB: description of the publication

Efectos orales y en la articulación temporomandibular del fenómeno de anticipación en pacientes con distrofia muscular de Steinert Oral effects and also in the temporomandibular joint for the anticipatory phenomenon in patients with Steinert's muscular dystrophy by Suely Nagahashi Marie, Iván Suazo Galdames, Antonio Sergio Guimarães

Connect to this object online.

Regulation and Effect of Taurine on Metabolism

Subjects: “…Duchenne Muscular Dystrophy…”
DOAB: download the publication
DOAB: description of the publication

Regulation and Effect of Taurine on Metabolism

Subjects: “…Duchenne Muscular Dystrophy…”
DOAB: download the publication
DOAB: description of the publication

Neuromuscular Disorders in Children and Adolescents

Subjects: “…Duchenne muscular dystrophy…”
DOAB: download the publication
DOAB: description of the publication

Muscle Homeostasis and Regeneration From Molecular Mechanisms to Therapeutic Opportunities

Subjects: “…muscular dystrophy…”
DOAB: download the publication
DOAB: description of the publication

Carotenoids by Sliwka, Hans-Richard

Subjects: “…Duchenne muscular dystrophy…”
DOAB: download the publication
DOAB: description of the publication